2021 ESPEN指南:急慢性肾脏病住院患者的临床营养

2021-02-09 欧洲临床营养和代谢学会 Clin Nutr ;S0261-5614(21)00052-2

急性肾病(AKD)(包括急性肾损伤(AKI))和慢性肾病(CKD)在住院患者中发病率很高,包括肾内科和内科病房、外科病房和重症监护室(ICU)的患者,它们具有重要的代谢和营养后果。此外,在开始肾脏替代

中文标题:

2021 ESPEN指南:急慢性肾脏病住院患者的临床营养

英文标题:

ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease

发布日期:

2021-02-09

简要介绍:

急性肾病(AKD)(包括急性肾损伤(AKI))和慢性肾病(CKD)在住院患者中发病率很高,包括肾内科和内科病房、外科病房和重症监护室(ICU)的患者,它们具有重要的代谢和营养后果。此外,在开始肾脏替代治疗(KRT)的情况下,无论采用何种方式,对营养状况、底物平衡和营养治疗过程可能产生的影响都不容忽视。本指南旨在为AKD和CKD住院患者的临床营养提供循证建议。由于该患者群体的显著异质性以及高质量证据数据的匮乏,本指南旨在作为证据和--在大多数情况下--专家意见的基本框架,通过结构化的共识过程进行汇总,以更新之前的两份ESPEN成人肾衰竭肠内(2006)和肠外(2009)营养指南。本指南将不涉及稳定的CKD患者的营养护理(即CKD四期和五期以下门诊患者的控制蛋白含量饮食/低蛋白饮食,有或没有氨基酸/酮类化合物整合)、肾移植的营养以及儿童肾病。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESPEN指南:急慢性肾脏病住院患者的临床营养.pdf)] GetToolGuiderByIdResponse(projectId=1, id=72da91c0020e1309, title=2021 ESPEN指南:急慢性肾脏病住院患者的临床营养, enTitle=ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease, guiderFrom=Clin Nutr ;S0261-5614(21)00052-2, authorId=0, author=, summary=急性肾病(AKD)(包括急性肾损伤(AKI))和慢性肾病(CKD)在住院患者中发病率很高,包括肾内科和内科病房、外科病房和重症监护室(ICU)的患者,它们具有重要的代谢和营养后果。此外,在开始肾脏替代, cover=https://img.medsci.cn/2021315/1615738353706_2020535.jpg, journalId=0, articlesId=null, associationId=374, associationName=欧洲临床营养和代谢学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Feb 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>急性肾病(AKD)(包括急性肾损伤(AKI))和慢性肾病(CKD)在住院患者中发病率很高,包括肾内科和内科病房、外科病房和重症监护室(ICU)的患者,它们具有重要的代谢和营养后果。此外,在开始肾脏替代治疗(KRT)的情况下,无论采用何种方式,对营养状况、底物平衡和营养治疗过程可能产生的影响都不容忽视。本指南旨在为AKD和CKD住院患者的临床营养提供循证建议。由于该患者群体的显著异质性以及高质量证据数据的匮乏,本指南旨在作为证据和--在大多数情况下--专家意见的基本框架,通过结构化的共识过程进行汇总,以更新之前的两份ESPEN成人肾衰竭肠内(2006)和肠外(2009)营养指南。本指南将不涉及稳定的CKD患者的营养护理(即CKD四期和五期以下门诊患者的控制蛋白含量饮食/低蛋白饮食,有或没有氨基酸/酮类化合物整合)、肾移植的营养以及儿童肾病。</p>, tagList=[TagDto(tagId=281, tagName=肾脏病)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=281, guiderKeyword=肾脏病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13203, appHits=372, showAppHits=0, pcHits=1956, showPcHits=12831, likes=1, shares=38, comments=19, approvalStatus=1, publishedTime=Mon Mar 15 00:36:48 CST 2021, publishedTimeString=2021-02-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 15 00:12:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:41:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESPEN指南:急慢性肾脏病住院患者的临床营养.pdf)])
2021 ESPEN指南:急慢性肾脏病住院患者的临床营养.pdf
下载请点击:
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2159256, encodeId=ff0d2159256aa, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97b78858876, createdName=ms8000000920375153, createdTime=Sat Sep 23 10:27:49 CST 2023, time=2023-09-23, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1055195, encodeId=a44d10551957e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14415122116, createdName=jyy589, createdTime=Sun Sep 26 23:32:31 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003278, encodeId=b2c210032e84b, content=急需, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c05516956, createdName=ms4000000555981994, createdTime=Wed Jul 28 11:23:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002780, encodeId=0dbc1002e8069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee62167588, createdName=yuanmeng-j, createdTime=Mon Jul 26 17:44:46 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977210, encodeId=9b649e72106a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ca5476292, createdName=ms9000000270071262, createdTime=Sun Jun 27 08:52:57 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2023-09-23 ms8000000920375153 来自天津

    需要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2159256, encodeId=ff0d2159256aa, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97b78858876, createdName=ms8000000920375153, createdTime=Sat Sep 23 10:27:49 CST 2023, time=2023-09-23, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1055195, encodeId=a44d10551957e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14415122116, createdName=jyy589, createdTime=Sun Sep 26 23:32:31 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003278, encodeId=b2c210032e84b, content=急需, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c05516956, createdName=ms4000000555981994, createdTime=Wed Jul 28 11:23:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002780, encodeId=0dbc1002e8069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee62167588, createdName=yuanmeng-j, createdTime=Mon Jul 26 17:44:46 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977210, encodeId=9b649e72106a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ca5476292, createdName=ms9000000270071262, createdTime=Sun Jun 27 08:52:57 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-09-26 jyy589

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2159256, encodeId=ff0d2159256aa, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97b78858876, createdName=ms8000000920375153, createdTime=Sat Sep 23 10:27:49 CST 2023, time=2023-09-23, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1055195, encodeId=a44d10551957e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14415122116, createdName=jyy589, createdTime=Sun Sep 26 23:32:31 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003278, encodeId=b2c210032e84b, content=急需, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c05516956, createdName=ms4000000555981994, createdTime=Wed Jul 28 11:23:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002780, encodeId=0dbc1002e8069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee62167588, createdName=yuanmeng-j, createdTime=Mon Jul 26 17:44:46 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977210, encodeId=9b649e72106a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ca5476292, createdName=ms9000000270071262, createdTime=Sun Jun 27 08:52:57 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-07-28 ms4000000555981994

    急需

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2159256, encodeId=ff0d2159256aa, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97b78858876, createdName=ms8000000920375153, createdTime=Sat Sep 23 10:27:49 CST 2023, time=2023-09-23, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1055195, encodeId=a44d10551957e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14415122116, createdName=jyy589, createdTime=Sun Sep 26 23:32:31 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003278, encodeId=b2c210032e84b, content=急需, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c05516956, createdName=ms4000000555981994, createdTime=Wed Jul 28 11:23:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002780, encodeId=0dbc1002e8069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee62167588, createdName=yuanmeng-j, createdTime=Mon Jul 26 17:44:46 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977210, encodeId=9b649e72106a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ca5476292, createdName=ms9000000270071262, createdTime=Sun Jun 27 08:52:57 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-07-26 yuanmeng-j

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2159256, encodeId=ff0d2159256aa, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97b78858876, createdName=ms8000000920375153, createdTime=Sat Sep 23 10:27:49 CST 2023, time=2023-09-23, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1055195, encodeId=a44d10551957e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14415122116, createdName=jyy589, createdTime=Sun Sep 26 23:32:31 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003278, encodeId=b2c210032e84b, content=急需, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c05516956, createdName=ms4000000555981994, createdTime=Wed Jul 28 11:23:36 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002780, encodeId=0dbc1002e8069, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee62167588, createdName=yuanmeng-j, createdTime=Mon Jul 26 17:44:46 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977210, encodeId=9b649e72106a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18ca5476292, createdName=ms9000000270071262, createdTime=Sun Jun 27 08:52:57 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-06-27 ms9000000270071262

    学习

    0

拓展阅读

中国成人糖尿病肾脏病临床诊断的专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2016-06-03

2019 SIN意见书:肾脏病患者高血钾的管理

意大利肾病学会(SIN,Italian Society of Nephrology) · 2019-05-22

2018 JSN/JRS/JCS指南:碘造影剂在肾脏病患者中的应用

日本肾脏病学会(JSN,Japanese Society of Nephrology) · 2019-11-11

2020 ACR/NKF共识声明:静脉注射碘造影剂在肾脏病患者中的应用

美国放射学会(ACR,American College of Radiology) · 2020-01-21